(E)-4'-Hydroxy-3'-methoxycinnamic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000068
Compound index — E
660 substances begin with E. 8 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, (E)-4'-Hydroxy-3'-methoxyc… – Enclomiphene.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
(E)-5-(p-hydroxystyryl)resorcinol CA-NHP Not yet graded
CA licensed ingredient
Market presence464 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000074
(E)-8-Methyl-N-vanillyl-6-nonenamide CA-NHP Not yet graded
CA licensed ingredient
Market presence74 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000084
(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000117
(E,E,E)-2-Methyl-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-1,4-napthalenedione CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000052
E-6005 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005372
E. coli adhesin F4 (F4ab, F4ac, F4ad) EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005368
E. coli adhesin F41 EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005369
E. coli adhesin F5 EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005370
E. coli adhesin F6 EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005371
E2 glycoprotein of classical swine fever virus EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI09AA06
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005373
E2 recombinant protein EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005374
EAS Creatine (EAS Phosphagen) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “EAS Creatine (EAS Phosphagen) is clinically tested to improve anaerobic work capacity” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005375
EAS Phosphagen Elite EU-CLAIM Not yet graded
EU claims 0 authorised / 5 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Amp up your workout with EAS Phosphagen Elite, clinically shown to improve ventilatory and lactate thresholds for greater cardiorespiratory endurance in intense workouts (training) EAS Phosphagen Elite is clinically shown to improve ventilatory and lactate thresholds” | Non-authorised | Art.13(1) | EFSA opinion |
| “EAS Phosphagen Elite is clinically shown to boost muscular strength EAS Phosphagen Elite is clinically shown to increase strength by up to 15% EAS Phosphagen Elite is designed to boost overall muscular strength Boost muscular strength” | Non-authorised | Art.13(1) | EFSA opinion |
| “EAS Phosphagen Elite is clinically shown to increase anaerobic threshold EAS Phosphagen Elite is clinically shown to increase physical working capacity at fatigue threshold” | Non-authorised | Art.13(1) | EFSA opinion |
| “EAS Phosphagen Elite is designed to provide a higher quality workout, and the addition of beta alanine appears to enhance average training volume more so than creatine alone EAS Phosphagen Elite is clinically shown to result in greater training volume threshold” | Non-authorised | Art.13(1) | EFSA opinion |
| “EAS Phosphagen Elite is designed to provide a higher quality workout, and the addition of beta alanine appears to enhance average training volume more so than creatine alone EAS Phosphagen Elite is clinically shown to result in greater training volume threshold” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005376
EAS Phosphagen HP EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “EAS Phosphagen HP can help improve total anaerobic work performed EAS Phosphagen HP is clinically tested to help improve anaerobic work capacity EAS Phosphagen HP can help improve total anaerobic work performed” | Non-authorised | Art.13(1) | EFSA opinion |
| “EAS Phosphagen HP is clinically shown to increase strength EAS Phosphagen HP is clinically shown to boost muscular strength EAS Phosphagen HP is designed to boost overall muscular strength” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005377
East Indian Lemongrass Oil US-DRUG Not yet graded
US: unapproved homeopathic
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005378
Eastern Oyster US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005379
Eberthinum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005380
Ebola virus Sudan Gulu strain GP EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07BX
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005381
Ebola virus Taï Forest strain nucleoprotein and the Marburg virus Musoke strain GP EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07BX
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005382
Ecallantide US-DRUG Not yet graded
US: bla
Class as recordedKallikrein Inhibitors [MoA]; Plasma Kallikrein Inhibitor [EPC]
Earliest US approval2009
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005383
Ecamsule US-DRUG Not yet graded
Earliest US approval2006
Market presence4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005384
Ecballium Elaterium Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005385
Ecdysterone ETALYN C/contestedband 4
also: beta-ecdysterone; 20-hydroxyecdysone; from Cyanotis or spinach extract
Recorded from — 0 of 7 registers
Etalyn identifierETA-C-005386
Ecgonine US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesCocaine precursor, in Coca leaves
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005387
Echinacea CA-NHP Not yet graded
CA licensed ingredient
Market presence82 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005388
Echinacea Angustifolia CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAcidifying Activity [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]
Market presence141 US product listings · 664 Canadian licensed products
Etalyn identifierETA-C-005389
Echinacea Angustifolia Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005390
Echinacea Angustifolia Whole US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Acidifying Activity [MoA]; Actively Acquired Immunity [PE]
Market presence256 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005391
Echinacea pallida CA-NHP Not yet graded
CA licensed ingredient
Market presence46 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005392
Echinacea Purpurea CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Antimalarial [EPC]
Market presence67 US product listings · 1,283 Canadian licensed products
Etalyn identifierETA-C-005393
Echinacea Purpurea Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005394
Echinacea Purpurea Whole US-DRUG Not yet graded
US: drug for further processing
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence32 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005395
Echinacea purpureae EU-NOVEL Not yet graded
Not novel in supplements
also: Brauneria purpurea (L.) Britton
Parts in scopeHerbs and Roots; Extract from cell cultures EchiPure-PC™.
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005396
Echinacea, Unspecified US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Allergens [Chemical/Ingredient]
Market presence244 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005397
Echinaceae angustifoliae radix EU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific data
also: Echinacea angustifolia DC.; Narrow-leaved coneflower root
Class as recordedherbal: Cough and cold
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-005398
Echinaceae pallidae radix EU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific data
also: Pale Coneflower Root; Echinacea pallida (Nutt.) Nutt.
Class as recordedherbal: Cough and cold
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-005399
Echinaceae purpureae radix EU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific data
also: Purple Coneflower Herb; Purple Coneflower Root; Echinaceae purpureae herba; Echinacea purpurea (L.) Moench
Class as recordedherbal: Skin disorders and minor wounds;Cough and cold
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-005400
Echinococcus Granulosus US-DRUG Not yet graded
US: unapproved homeopathic
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005401
Echinops latifolius CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005402
Echium oil EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Echium oil contains omega-3 fatty acid, stearidonic acid, which is efficiently metabolized in the body to anti-inflammatory n-3 LC PUFA's, i.e. EPA and DPA. Echium oil contains omega-6 fatty acid, y-linoleic acid, which is efficiently metabolized in the body.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps control levels of blood triglycerides” | Non-authorised | Art.13(1) | EFSA opinion |
| “Precursor of prostaglandins which are associated with many of the body's metabolic functions (immune system, reduction of inflammation).” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005403
Echium plantagineum CA-NHP Not yet graded
CA licensed ingredient
Market presence33 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005404
Echium Plantagineum Seed Oil US-DRUG Not yet graded
US: otc monograph drug
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005405
Echium vulgare L. EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeLeaves and flowers; Oil
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005406
Echothiophate Iodide US-DRUG Not yet graded
US: bulk ingredient for human prescription compounding
Earliest US approval1960
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005407
Ecklonia cava CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005408
Ecklonia Cava Extract CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005409
Ecklonia cava Kjellman 1885 EU-NOVEL Not yet graded
Not novel in supplements
also: Ecklonia latifolia Kjellman 1885
Parts in scopeWhole; Ecklonia cava phlorotannins
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005410
Ecklonia kurome CA-NHP Not yet graded
CA licensed ingredient
Market presence40 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005411
Eclipta alba CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005412
Eclipta prostrata CA-NHP Not yet graded
CA licensed ingredient
Market presence141 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005413
Eclipta Prostrata Whole US-DRUG Not yet graded
US: otc monograph drug
Class as recordedBlood Coagulation Factor [EPC]; Calcium [CS]; Cations; Divalent [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005414
Ecnoglutide ETALYNUS-DRUG C/supportedband 2
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005415
Econazole Nitrate US-DRUG Not yet graded
US: anda
Class as recordedAzole Antifungal [EPC]; Azoles [CS]
Earliest US approval1982
Market presence20 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005416
Ecopipam Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005417
Ectoin US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005418
Eculizumab EU-MEDUS-DRUG Not yet graded
Eculizumab-Aagh US-DRUG Not yet graded
US: drug for further processing
Earliest US approval2024
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005420
Eculizumab-Aeeb US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005421
Edetate Disodium US-DRUG Not yet graded
US: anda
Class as recordedAllergens [CS]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Cell-mediated Immunity [PE]
Earliest US approval1953
Market presence7 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005423
Edetic Acid US-DRUG Not yet graded
US: otc monograph final
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005424
Edible bird nest EU-NOVEL Not yet graded
Not novel in food
Parts in scopeEdible bird nest
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005425
Edible Oyster US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005426
Edible Rock Crab US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Corticosteroid Hormone Receptor Agonists [MoA]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005427
Edotreotide Gallium GA-68 US-DRUG Not yet graded
US: nda
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005429
Edoxaban US-DRUG Not yet graded
US: bulk ingredient
Class as recordedFactor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]
Earliest US approval2015
Market presence18 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005430
edoxaban tosilate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB01; B01AF03
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005431
Edrophonium Chloride US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1951
Market presence1 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005432
Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) EU-CLAIM Not yet graded
EU claims 0 authorised / 5 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Efalex® may help maintain coordination.” | Non-authorised | Art.14(1)(b) | EFSA opinion |
| “Efalex® may help maintain concentration.” | Non-authorised | Art.14(1)(b) | EFSA opinion |
| “Efalex® may help maintain and support brain development and function” | Non-authorised | Art.14(1)(b) | EFSA opinion |
| “Efalex® may help maintain learning ability” | Non-authorised | Art.14(1)(b) | EFSA opinion |
| “Efalex® may help maintain and support eye development and function.” | Non-authorised | Art.14(1)(b) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005433
efalizumab EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedL04AA21
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005434
Efavirenz EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedCytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]
Earliest US approval1998
Market presence42 US product listings · 47 FDA applications · 7 EU medicines
Etalyn identifierETA-C-005436
Efavirenz, Emtricitabine And Tenofovir Alafenamide US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005437
Efbemalenograstim Alfa EU-MEDUS-DRUG Not yet graded
Efbemalenograstim Alfa-Vuxw US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005439
EffEXT™ EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps to support joint function by maintaining low levels of plasma C-reactive protein” | Non-authorised | Art.13(5) | EFSA opinion |
| “Contributes to support joint flexibility” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010738
Efgartigimod Alfa EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedEndoglycosidase [EPC]; Glycoside Hydrolases [CS]; L04AA58; Neonatal Fc Receptor Blocker [EPC]
Earliest US approval2021
Market presence7 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005440
Efgartigimod Alfa And Hyaluronidase-Qvfc US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005441
Efinaconazole US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAzole Antifungal [EPC]; Azoles [CS]
Earliest US approval2014
Market presence18 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005442
Eflapegrastim US-DRUG Not yet graded
US: bla
Class as recordedGranulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005443
Eflapegrastim-Xnst US-DRUG Not yet graded
Earliest US approval2022
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005444
eflornithine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedAntiprotozoal [EPC]; D11AX; Decarboxylase Inhibitor [EPC]; Decarboxylase Inhibitors [MoA]
Earliest US approval1990
Market presence9 US product listings · 3 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005445
Egcg CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005448
EGG US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Ascorbic Acid [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005449
egg albumen CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005450
egg drop syndrome virus vaccine (inactivated) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005451
EGG Phospholipids US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence27 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005452
EGG Shell US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Cations
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005453
EGG Shell Membrane CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence4 US product listings · 3 Canadian licensed products
Etalyn identifierETA-C-005456
EGG Shell, Cooked US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Animal Fur [CS]; Ascorbic Acid [CS]; Bee Venoms [CS]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005454
Egg shell, crushed, without membrane EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “It maintains the good condition of bonesIt protects and nourishes bones, it is a suitable source of calcium for bone restoration.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005455
EGG White US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Calculi Dissolution Agent [EPC]; Catecholamine [EPC]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005457
EGG Yolk US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Dietary [CS]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005458
Egg yolk protein CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005459
Eggdrop syndrome-1976 virus EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005460
Eggplant US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Bee Venoms [CS]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005461
Ehrendorferia Chrysantha Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005462
Ehrlichia Canis US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fungal Proteins [CS]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005463
Ehrlichia Chaffeensis US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCalculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005464
Eichhornia crassipes CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005465
Eichhornia Crassipes Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005466
Eicosapentaenoic acid CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 5 refusedCA licensed ingredient
Market presence1 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Contributes to emotional balance / helps maintain a positive mood.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Contributes to good quality of cholesterol particles. Contributes to good quality cholesterol.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps improve appetite during recovery or recuperation.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Supports the ability to concentrate. Supports learning abilities. EPA helps to calm down. EPA offers rest for mind and body.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Supports the ability to concentrate. Supports learning abilities. EPA helps to calm down. EPA offers rest for mind and body.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-005467
Eicosapentaenoic acid and docosahexaenoic acid (EPA/DHA) EU-CLAIM Not yet graded
EU claims 1 authorised / 0 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “EPA and DHA contribute to the normal function of the heart” | Authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005468
Eicosapentanoic acid (EPA) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “EPA has been shown to reduce the AA/EPA ratio in blood. A high AA/EPA level is a risk factor in the development of attention difficulties in children with ADHD-like symptoms. These children are also characterised by less hyperactivity and/or coexisting oppositional behaviour.” | Non-authorised | Art.14(1)(a) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010735
EIDD-2801 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005469
Eimeria acervulina EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005470
Eimeria maxima EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005471
Eimeria mitis EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005472
Eimeria praecox EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005473
Eimeria tenella EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005474
Eisenia bicyclis EU-NOVEL Not yet graded
Not novel in food
also: Ecklonia bicyclis Kjellman 1885, Eisenia arborea f. bicyclis (Kjellman) Yendo 1902, Ecklonia wrightii Harvey 1860
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005475
Elacestrant EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: drug for further processing
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; L02BA
Earliest US approval2023
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005476
Elaeagnus Angustifolia Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005478
Elaeagnus Angustifolia Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005479
Elaeis guineensis CA-NHP Not yet graded
CA licensed ingredient
Market presence164 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005480
Elaeis Guineensis Fruit US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Bismuth [CS]; Bismuth [EPC]; Blood Coagulation Factor [EPC]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005481
Elaeis Oleifera Kernel Oil US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005482
Elaeocarpus angustifolius CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005483
Elagolix US-DRUG Not yet graded
US: bulk ingredient
Class as recordedCytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]
Earliest US approval2018
Market presence15 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005485
Elagolix Sodium,estradiol,norethindrone Acetate US-DRUG Not yet graded
Earliest US approval2020
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005487
Elagolix, Estradiol And Norethindrone Acetate And Elagolix US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005486
Elamipretide ETALYNUS-DRUG C/not supportedband 5
US: bulk ingredient
Earliest US approval2025
Market presence8 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005488
Elancyl Global Silhouette®, a combined product containing either conjugated linoleic acid or a mix extract of plants and cocoa extract as active ingredients EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Clinically tested as of 14 days. Your silhouette is apparently and globally redrawn, resculpted and refined at 28 days” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005489
Elapegademase US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005490
Elapegademase-Lvlr US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005491
Elaphe taeniura CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005492
Elaps corallinus CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005493
Elastin US-DRUG Not yet graded
US: unapproved drug other
Class as recordedCentral Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Methylxanthine [EPC]; Xanthines [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005494
Elastin hydrolysate CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005495
Elaterium CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005496
Elbasvir EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HCV NS3/4A Protease Inhibitors [MoA]; Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]
Earliest US approval2016
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005497
Elecampane root CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005498
Eleocharis dulcis EU-NOVEL Not yet graded
Not novel in food
also: Eleocharis equisetina, E. indica, E. plantaginea, E. plantaginoides, E. tuberosa, E. tumida.
Parts in scopeRoot (tuber, corm)
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005499
Eletriptan Hydrobromide US-DRUG Not yet graded
US: anda
Class as recordedSerotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
Earliest US approval2002
Market presence31 US product listings · 11 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005500
Elettaria cardamomum CA-NHP Not yet graded
CA licensed ingredient
Market presence79 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005501
Elettaria cardamomum var. cardamomum CA-NHP Not yet graded
CA licensed ingredient
Market presence78 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005502
Elettaria Cardamomum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005503
Elettaria Ensal Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005504
Eleuthero US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Cations
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005505
Eleutherococcus gracilistylus CA-NHP Not yet graded
CA licensed ingredient
Market presence70 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005506
Eleutherococcus senticosus CA-NHP Not yet graded
CA licensed ingredient
Market presence1,890 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005507
Eleutherococcus Senticosus Root Oil US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCopper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005508
Eleutherococcus Senticosus Stem US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005509
Eleutherococcus Senticosus Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005510
Elexacaftor, Ivacaftor, Tezacaftor US-DRUG Not yet graded
Earliest US approval2019
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005512
Eliglustat EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedA16AX10; Cytochrome P450 2D6 Inhibitors [MoA]; Glucosylceramide Synthase Inhibitor [EPC]; Glucosylceramide Synthase Inhibitors [MoA]
Earliest US approval2014
Market presence8 US product listings · 7 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005513
Ellagic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005516
ELM US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Allergens [Chemical/Ingredient]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005517
Elobixibat Monohydrate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005518
Elosulfase Alfa US-DRUG Not yet graded
US: bla
Class as recordedHydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]; alpha-Glucosidases [CS]
Earliest US approval2014
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005519
Elotuzumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAntibodies; L01FX08; Monoclonal [CS]; SLAMF7-directed Antibody Interactions [MoA]
Earliest US approval2015
Market presence6 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005520
Eltanolone US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005522
Eltrombopag EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedB02BX05; Breast Cancer Resistance Protein Inhibitors [MoA]; Increased Megakaryocyte Maturation [PE]; Increased Platelet Production [PE]
Earliest US approval2008
Market presence83 US product listings · 13 FDA applications · 2 EU medicines
Etalyn identifierETA-C-005523
Eltrombopag Choline US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Increased Megakaryocyte Maturation [PE]; Increased Platelet Production [PE]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
Earliest US approval2023
Market presence6 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005524
Eluxadoline EU-MEDUS-CSAUS-DRUG Not yet graded
CSA Schedule IVEU medicine: WithdrawnUS: bulk ingredient
Class as recordedA07; DEA: narcotic / opioid; Opioid mu-Receptor Agonists [MoA]; mu-Opioid Receptor Agonist [EPC]
Earliest US approval2015
Market presence6 US product listings · 5 FDA applications · 1 EU medicines
DEA other namesVIBERZI
Etalyn identifierETA-C-005525
Elvitegravir EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitor [EPC]
Earliest US approval2012
Market presence10 US product listings · 3 FDA applications · 3 EU medicines
Etalyn identifierETA-C-005526
Elvitegravir, Cobicistat, Emtricitabine And Tenofovir Alafenamide US-DRUG Not yet graded
Earliest US approval2026
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005527
Elymus Repens Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence14 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005528
Elymus Repens Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence36 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005529
Elymus repens subsp. repens CA-NHP Not yet graded
CA licensed ingredient
Market presence25 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005530
Elymus Repens Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005531
Elytrigia repens CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005532
Emapalumab-Lzsg US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005612
Embelia ribes CA-NHP Not yet graded
CA licensed ingredient
Market presence28 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005613
Embelia Ribes Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAnti-Inflammatory Agents; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005614
Emblica officinalis CA-NHPEU-CLAIMEU-NOVEL Not yet graded
Not novel in supplementsEU claims 0 authorised / 4 refusedCA licensed ingredient
also: Phyllanthus emblica L.
Market presence39 Canadian licensed products
Parts in scopeFruit
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Softens the mucous membrane of throat” | Non-authorised | Art.13(1) | EFSA opinion |
| “-Helps to promote healthy ageing -Helps to protect from oxidative cell /DNA damage” | Non-authorised | Art.13(1) | EFSA opinion |
| “-Helps to promote healthy ageing -Helps to protect from oxidative cell /DNA damage” | Non-authorised | Art.13(1) | EFSA opinion |
| “Contains naturally occurring antioxidants Antioxidants help protect you from radicals which cause cell damage Antioxidants help protect your cells and tissues from oxidative damage Antioxidants contribute to the total antioxidant capacity of the body and may help strengthen our body´s defences; Contains antioxidant/s Is a source of antioxdiant/s. With antioxidant/s.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-005615
Emblica Officinalis Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005616
Emblica officinalis FRUIT RIND EU-CLAIM Not yet graded
EU claims 0 authorised / 9 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Supports heart function and blood quality. Contributes to normal cholesterol. Contributes to the health of the cardiovascular system” | Non-authorised | Art.13(1) | EFSA opinion |
| “Supports mental function. Helps maintain freedom from pain in the head. Improves the body's resistance to stress. Helps the body to deal with stress” | Non-authorised | Art.13(1) | EFSA opinion |
| “Supports the digestion and metabolism of sugars. Helps to maintain normal blood glucose level.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Supports the reproductive and urinary systems” | Non-authorised | Art.13(1) | EFSA opinion |
| “Gives strength and energy. Helps build muscle.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Has a gentle cleansing action. Helps neutralise toxins” | Non-authorised | Art.13(1) | EFSA opinion |
| “Has a gentle cleansing action. Helps neutralise toxins” | Non-authorised | Art.13(1) | EFSA opinion |
| “Strengthens the immune systen. Strengthens the body's natural defenses. -Strengthens the body's natural defenses. Helps maintain the immune system, the body's natural defenses. Contains a high amount of naturally occurring antioxidants -Antioxidants help protect you from radicals which cause cell damage/antioxidants help protect your cells, tissues and organs from oxidative damage Antioxidants contribute to the…” | Non-authorised | Art.13(1) | EFSA opinion |
| “Supports eye function” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005617
Embryo suis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005618
Embutramide US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: depressant
DEA other namesTributane
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005619
Emetinum CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005621
Emicizumab-Kxwh US-DRUG Not yet graded
US: drug for further processing
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005623
Emideltide US-DRUG Not yet graded
US: bulk ingredient
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005624
Emodin US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005626
Empagliflozin EU-MEDUS-DRUG Not yet graded
Empagliflozin, Metformin Hydrochloride US-DRUG Not yet graded
Earliest US approval2026
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005628
Empetrum nigrum EU-NOVEL Not yet graded
Not novel in food
also: Chamaetaxus nigra (L.) Bubani
Parts in scopeFruit
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005629
Emtricitabine EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inducers [MoA]
Earliest US approval2003
Market presence120 US product listings · 48 FDA applications · 19 EU medicines
Etalyn identifierETA-C-005630
Emtricitabine, Tenofovir Alafenamide US-DRUG Not yet graded
Earliest US approval2024
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005631
Enalapril Maleate EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAngiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; C09AA02; Decreased Blood Pressure [PE]
Earliest US approval1985
Market presence122 US product listings · 36 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005633
Enalaprilat US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Decreased Blood Pressure [PE]
Earliest US approval1988
Market presence6 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005634
Enasidenib Mesylate US-DRUG Not yet graded
US: nda
Class as recordedIsocitrate Dehydrogenase 2 Inhibitor [EPC]; Isocitrate Dehydrogenase 2 Inhibitors [MoA]
Earliest US approval2017
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005635
Encequidar Mesylate Monohydrate US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005636
enclomifene citrate EU-MED Not yet graded
EU medicine: Refused
Class as recordedG03X
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005637
Enclomiphene ETALYNUS-DRUG B/supportedband 1
US: bulk ingredient
Market presence23 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005638